Abstract
Sentinel lymph node biopsy (SLNB) is a procedure for lymphatic staging in early breast cancer. In a valid SLNB procedure, axillary lymph node dissection (ALND) can be omitted in nodenegative caseswithout compromising patient safety. The SLNB technology has also dramatically improved the quality of life for women with breast cancer. This report details a brief history of SLNB, the main methods to identify sentinel node and how it was applied in the treatment of a breast cancer.
Résumé
La technique du ganglion sentinelle (GS) est une méthode fiable permettant une évaluation chirurgicale sélective de l’aisselle. Cette procédure permet également de réduire la morbidité du geste axillaire en comparaison au curage axillaire (CA). Cet article rappelle l’historique du développement de la procédure du GS, les méthodes de détection et les indications actuellement admises en France.
Similar content being viewed by others
Références
Barranger E, Classe J, Clough K, et al. (2011) Veille bibliographique et recom-mandation. Chirurgie du sein et axillaire. RPC Nice-Saint-Paul-de-Vence 2011. Oncologie 13: 727–754
Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 39: 456–466
Dewar JA, Sarrazin D, Benhamou E, et al. (1987) Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 13: 475–481
Eroglu A, Mudun A, Berberoglu K, et al. (2004) Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. Clin Nucl Med 29: 306–311
Fisher B, Jeong JH, Anderson S, et al. (2002) Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347: 567–575
Fisher B, Redmond C, Fisher ER, et al. (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674–681
Giuliano AE, Kirgan DM, Guenther JM, et al. (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391–398; discussion 398–401
Gould EA, Winship T, Philbin PH, et al. (1960) Observations on a “sentinel node” in cancer of the parotid. Cancer 13: 77–78
Goyal A, Newcombe RG, Chhabra A, et al. (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer: results of the ALMANAC validation phase. Breast Cancer Res Treat 99: 203–208
Hunt KK, Ballman KV, McCall LM, et al. (2012) Factors associated with localregional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann Surg 256: 428–436
Kavallaris A, Camara O, Runnebaum IB (2008) Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine. J Cancer Res Clin Oncol 134: 667–672
Kern KA (2001) Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid: illustrated technique. J Am Coll Surg 192: 545–550
Kern KA (1999) Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 189: 539–545
Krag DN, Anderson SJ, Julian TB, et al. (2007) Technical outcomes of sentinellymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8: 881–888
Krag DN, Anderson SJ, Julian TB, et al. (2010) Sentinel-lymph-node resection compared with conventional axillarylymph-node dissection in clinically nodenegative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11: 927–933
Linehan DC, Hill AD, Akhurst T, et al. (1999) Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6: 450–454.
Louis-Sylvestre C, Clough K, Asselain B, et al. (2004) Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22: 97–101
Lyman GH, Giuliano AE, Somerfield MR, et al. (2005) American Society of Clinical Oncology guideline recommendations for sentinel-lymph-node biopsy in earlystage breast cancer. J Clin Oncol 23: 7703–7720
Martelli G, Boracchi P, Ardoino I, et al. (2012) Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial. Ann Surg 256: 920–924
McMasters KM, Wong SL, Martin RC, 2nd, et al. (2001) Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann Surg 233: 676–687
Nieweg OE, Estourgie SH, van Rijk MC, et al. (2004) Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients. J Surg Oncol 87: 153–156
Orr RK (1999) The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann Surg Oncol 6: 109–116
Recht A, Pierce SM, Abner A, et al. (1991) Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9: 988–996
Rodier JF, Velten M, Wilt M, et al. (2007) Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol 25: 3664–3669
Sanghani M, Balk EM, Cady B (2009) Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis. Cancer 115: 1613–1620
Sapey M (1834) Injection, préparation et conservation des vaisseaux lymphatiques. Thèse pour le doctorat en médecine, no 241. Rignoux Imprimeur de la Faculté de Médecine, Paris
Zavagno G, De Salvo GL, Scalco G, et al. (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247: 207–213
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Barranger, E., Delpech, Y. Du curage axillaire au ganglion sentinelle: historique, technique et indications. Oncologie 15, 294–298 (2013). https://doi.org/10.1007/s10269-013-2298-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-013-2298-2